Who Supplies Valsartan? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Valsartan exports, with 259+ registered manufacturers shipping to buyers across 119+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 27.9% (export value: $54.9M). Close behind, MACLEODS PHARMACEUTICALS LTD (18.3%, $36.1M). ALEMBIC PHARMACEUTICALS LIMITED (4.5%, $8.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Valsartan? Top Manufacturers & Their Buyers
Flow of Valsartan from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Valsartan Supplier Network — Key Market Intelligence
The Valsartan export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 27.9% share, shipping $54.9M worth of product across 578 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $36.1M (18.3%) to the overall market. Combined, the top two suppliers alone account for 46.2% of all Valsartan exports, indicating a relatively concentrated supply base.
Across all 259 tracked manufacturers, the total Valsartan export value stands at $196.9M from 6.1K shipments. The market average shipment value is $32.3K. The single largest buyer relationship in terms of trade value is MYLAN PHARMACEUTICALS INC, receiving $34.0M worth of product.
The combined buyer network spans 14 named purchasing companies, including MYLAN PHARMACEUTICALS INC, MYLAN HUNGARY KFT,, MACLEODS PHARMA USA INC, NEXTPHARMA LOGISTICS GMBH, HEUMANN PHARMA GMBH and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Valsartan exporter from India, with a market share of 27.9% and a total export value of $54.9M across 578 shipments. Their average shipment value of $95.0K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC is the dominant customer, accounting for 61.9% of this supplier's tracked business. Top customers include:
• MYLAN PHARMACEUTICALS INC — $34.0M across 358 shipments (61.9% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $8.2M across 87 shipments (15.0% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $8.2M across 86 shipments (14.9% of this supplier's total exports)
• MYLAN HUNGARY KFT, — $2.5M across 26 shipments (4.5% of this supplier's total exports)
• MYLAN PHARMACEUTICALS INC — $2.0M across 21 shipments (3.6% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $95.0K is 194% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Valsartan exporter from India, with a market share of 18.3% and a total export value of $36.1M across 558 shipments. Their average shipment value of $64.7K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MACLEODS PHARMA USA INC — $12.7M across 196 shipments (35.2% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $11.7M across 182 shipments (32.5% of this supplier's total exports)
• NEXTPHARMA LOGISTICS GMBH — $9.0M across 139 shipments (24.9% of this supplier's total exports)
• MACLEODS PHARMA USA INC — $1.7M across 26 shipments (4.6% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $1.0M across 16 shipments (2.8% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $64.7K is 100% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
3ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Valsartan exporter from India, with a market share of 4.5% and a total export value of $8.8M across 270 shipments. Their average shipment value of $32.6K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• J. KNIPPER & COMPANY — $3.9M across 119 shipments (44.2% of this supplier's total exports)
• J. KNIPPER & COMPANY — $2.1M across 64 shipments (23.8% of this supplier's total exports)
• J. KNIPPER & COMPANY — $1.1M across 34 shipments (12.5% of this supplier's total exports)
• J. KNIPPER & COMPANY — $923.9K across 28 shipments (10.5% of this supplier's total exports)
• J. KNIPPER & COMPANY — $792.7K across 24 shipments (9.0% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $32.6K is 1% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
4SANDOZ PRIVATE LIMITED
SANDOZ PRIVATE LIMITED is the fourth-largest Valsartan exporter from India, with a market share of 3.7% and a total export value of $7.3M across 150 shipments. Their average shipment value of $48.9K is above the market average of $32.3K, suggesting premium or bulk contract pricing.
SANDOZ PRIVATE LIMITED serves 5 named buyers in our database. LEK D.D is the dominant customer, accounting for 55.6% of this supplier's tracked business. Top customers include:
• LEK D.D — $4.1M across 83 shipments (55.6% of this supplier's total exports)
• SANDOZ CANADA INC. — $1.4M across 29 shipments (19.1% of this supplier's total exports)
• LEK D.D — $793.7K across 16 shipments (10.8% of this supplier's total exports)
• SANDOZ CANADA INC. — $598.7K across 12 shipments (8.2% of this supplier's total exports)
• LEK D D PAKIRNI CENT — $464.9K across 10 shipments (6.3% of this supplier's total exports)
Key Insight: SANDOZ PRIVATE LIMITED's per-shipment value of $48.9K is 51% above the market average of $32.3K, consistent with large-order contracts or value-added formulations.
5AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the fifth-largest Valsartan exporter from India, with a market share of 2.5% and a total export value of $4.9M across 170 shipments. Their average shipment value of $28.6K is below the market average of $32.3K, reflecting a high-volume, competitive pricing strategy.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• KAWKAB SCIENTIFIC BUREAU* — $1.7M across 60 shipments (35.5% of this supplier's total exports)
• AL-THURAYA SCIENTIFI — $1.5M across 54 shipments (31.5% of this supplier's total exports)
• KAWKAB SCIENTIFIC BUREAU* — $840.4K across 29 shipments (17.3% of this supplier's total exports)
• HAWKARY PHARMACEUITC — $455.1K across 16 shipments (9.4% of this supplier's total exports)
• SHAMS AL THURAYA CO — $311.3K across 11 shipments (6.4% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED operates with high shipment frequency (170 shipments) at a per-shipment value of $28.6K, indicating a broad distribution network with many smaller, regular orders.
6DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the fifth-largest Valsartan exporter from India, with a market share of 1.7% and a total export value of $3.3M across 163 shipments. Their average shipment value of $20.2K is below the market average of $32.3K, reflecting a high-volume, competitive pricing strategy.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR REDDYS LABORATORIES INC — $1.4M across 68 shipments (41.9% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $807.0K across 40 shipments (24.5% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $728.1K across 36 shipments (22.1% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $272.4K across 13 shipments (8.3% of this supplier's total exports)
• DR REDDYS LABORATORIES INC — $105.8K across 5 shipments (3.2% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (163 shipments) at a per-shipment value of $20.2K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Valsartan Flows
Once Valsartan leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $196.9M. United States absorbs the largest share at 60.8% ($119.8M), followed by Germany (6.2%) and Slovenia (4.9%).
In United States — the top destination — named importers include MYLAN PHARMACEUTICALS INC,, MACLEODS PHARMA USA ,INC, MACLEODS PHARMA USA,INC. In Germany, key buyers are NEXTPHARMA LOGISTICS GMBH.
This geographic spread reflects Valsartan's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Valsartan Go? Top Importing Countries & Their Buyers
Trade flow of Valsartan exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Valsartan imports from India, with a total trade value of $119.8M across 676 shipments — representing a 60.8% share of all Valsartan exports. The average shipment value of $177.2K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 12 tracked buyers.
Named Valsartan importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 31.3% ($37.5M) of this market's total imports.
• MYLAN PHARMACEUTICALS INC, — $37.5M (31.3% of United States's total)
• MACLEODS PHARMA USA ,INC — $13.1M (10.9% of United States's total)
• MACLEODS PHARMA USA,INC — $11.9M (10.0% of United States's total)
Key Insight: United States's per-shipment average of $177.2K (449% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Valsartan imports from India.
2Germany
Germany ranks as the second-largest destination for Valsartan imports from India, with a total trade value of $12.3M across 11 shipments — representing a 6.2% share of all Valsartan exports. The average shipment value of $1.1M is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valsartan importers in Germany: NEXTPHARMA LOGISTICS GMBH is the largest buyer, accounting for 74.5% ($9.1M) of this market's total imports.
• NEXTPHARMA LOGISTICS GMBH — $9.1M (74.5% of Germany's total)
Key Insight: Germany's per-shipment average of $1.1M (3351% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Valsartan imports from India.
3Slovenia
Slovenia ranks as the third-largest destination for Valsartan imports from India, with a total trade value of $9.6M across 67 shipments — representing a 4.9% share of all Valsartan exports. The average shipment value of $143.7K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valsartan importers in Slovenia: LEK D.D is the largest buyer, accounting for 71.4% ($6.9M) of this market's total imports.
• LEK D.D — $6.9M (71.4% of Slovenia's total)
Key Insight: Slovenia's per-shipment average of $143.7K (345% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Slovenia is a key market for Valsartan imports from India.
4Hungary
Hungary ranks as the fourth-largest destination for Valsartan imports from India, with a total trade value of $7.1M across 90 shipments — representing a 3.6% share of all Valsartan exports. The average shipment value of $78.6K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valsartan importers in Hungary: MYLAN HUNGARY KFT, is the largest buyer, accounting for 66.8% ($4.7M) of this market's total imports.
• MYLAN HUNGARY KFT, — $4.7M (66.8% of Hungary's total)
Key Insight: Hungary's per-shipment average of $78.6K (143% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Hungary is a key market for Valsartan imports from India.
5Iraq
Iraq ranks as the fifth-largest destination for Valsartan imports from India, with a total trade value of $6.7M across 78 shipments — representing a 3.4% share of all Valsartan exports. The average shipment value of $85.5K is above the global average of $32.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Valsartan importers in Iraq: KAWKAB SCIENTIFIC BUREAU* is the largest buyer, accounting for 36.2% ($2.4M) of this market's total imports.
• KAWKAB SCIENTIFIC BUREAU* — $2.4M (36.2% of Iraq's total)
Key Insight: Iraq's per-shipment average of $85.5K (165% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iraq is a key market for Valsartan imports from India.
People Also Ask — Valsartan Supplier & Trade Network
Who are the top suppliers of Valsartan from India?+
Which companies buy Valsartan from Indian manufacturers?+
Where does Valsartan exported from India go?+
What is the market share of the top Valsartan supplier from India?+
What is the average shipment value for Valsartan exports from India?+
Is Valsartan manufactured in India and exported globally?+
Which country imports the most Valsartan from India?+
Who are the buyers of Valsartan in Germany?+
How concentrated is the Valsartan supplier market in India?+
How do I find verified buyers for Valsartan in specific countries?+
Valsartan Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Valsartan exporter with a 27.9% market share and $54.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 259 suppliers collectively account for 58.5% of all tracked Valsartan exports, with a combined trade value of $196.9M.
- 3United States is the largest destination market, absorbing 60.8% of India's Valsartan exports ($119.8M). Germany (6.2%) and Slovenia (4.9%) follow.
- 4With 6.1K total shipments averaging $32.3K each, the Valsartan export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN PHARMACEUTICALS INC, MYLAN PHARMACEUTICALS INC, MACLEODS PHARMA USA INC, MACLEODS PHARMA USA INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 119 countries
Network value: $196.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Valsartan.
- 2.Flow Mapping: 259 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 6,098 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 119 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,098 Verified Shipments
259 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists